EndocanENDO
13F holders, Q4 2024 (December 31)1holders
0new positions
0sold out
$0.00avg. 13F price*
At the end of Q4 2024, 1 institutions reported holding Endocan Corp. (ENDO) in their 13F filings, unchanged from Q3 2024. 0 opened new positions and 0 sold out. The largest holder was HighPoint Advisor Group LLC ($1).
- Company
- Endocan Corp.
- CUSIP
- 29271J109
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| HighPoint Advisor Group LLC | 0.00% | No change | 12,000 | $1 |
"% of holder's portfolio" is ENDO's weight in each manager's 13F, not the share of Endocan Corp. the manager owns.